Pharmaceutical Executive
Record capital flows across global public and private markets has opened up new channels of investment in early-stage and novel science.
James Leech
Advertisement
Articles by James Leech
Advertisement
Latest Updated Articles
Cross-Border Funding in the Life SciencesAugust 21st 2018
Advertisement
Advertisement
Trending on PharmExec
1
Pharma M&A Roundup: Servier Acquiring Edgewise Therapeutics' Muscular Dystrophy Business, Hanmi Enters Licensing Agreement with Eli Lilly, Avenzo Enters Merger Agreement with Rallybio
2
FDA Approves Xocova as First Oral Post-Exposure Covid-19 Prevention Therapy
3
CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo
4
Why Breakthrough Cell and Gene Therapies Still Fail at the Finish Line
5